Search Results | DrugBank Online

Did you mean iodine and potassium iodine?

Displaying drugs 12876 - 12900 of 14359 in total

ST-36

ST-36 is a cell-penetrating dominant-negative form of activating transcription factor 5. In 2017, it received orphan drug designation by the FDA for the treatment of glioma.

Investigational

IMAB027

IMAB027 is a chimeric monoclonal antibody against Claudin 6.

Investigational

LV305

LV305 is a lentiviral vector encoding NY-ESO-1 gene. LV305 is an active component of CMB305 along with G305.

Investigational

Leuvectin (formerly known as VCL-1102) is a component of gene therapy along with cationic lipid 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE).

Investigational

KTH-222

Investigational

Liposomal N-acetylglucosminyl-N-acetylmuramly-L-Ala-D-isoGln-L-Ala-gylceroldipalmitoyl

Investigational

Belzupacap Sarotalocan

Investigational

ADXS-31164

Investigational

Eltrapuldencel-T

Investigational

Inalimarev

Investigational

IMGN779

Investigational

ICG-140

Investigational

MORAb-066

MORAb-066 is a humanized antibody directed against tissue factor (TF). It is being investigated in pancreatic cancer.

Investigational

OBI-999

Investigational

STM-217

Investigational

Autologous DNP-conjugated tumour vaccine

Autologous DNP-conjugated tumour vaccine, or melanoma vaccine, is an investigational autologous cell vaccine technology for melanoma.

Investigational

RR001

RR001 is an investigational gene therapy consisting of autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand (AD-PC sTRAIL).

Investigational